There are 383 resources available
Molecular mechanisms and approaches to treating resistance to first line osimertinib in EGFR-mutant lung cancer
Presenter: Tony S.K. Mok
Session: EGFR, Exon 20 and ALK
Resources:
Slides
Webcast
EGFR exon 20 insertions: Science and emerging therapies
Presenter: Alfredo Addeo
Session: EGFR, Exon 20 and ALK
Resources:
Slides
Webcast
Updates on ALK: TKIs and beyond
Presenter: Myung-Ju Ahn
Session: EGFR, Exon 20 and ALK
Resources:
Slides
Webcast
Q&A
Session: EGFR, Exon 20 and ALK
Resources:
Webcast
Oligometastatic NSCLC: Who benefits the most?
Presenter: Willemijn Theelen
Session: Long terms responders
Resources:
Slides
Webcast
Long term responders to chemotherapy / antiangiogenics
Presenter: Sara Pilotto
Session: Long terms responders
Resources:
Slides
Webcast
Lung cancer needs from a psychosocial perspective: A professional’s point of view
Presenter: Laszlo Degi Csaba
Session: Living with lung cancer: Meeting unmet needs (LuCE and IASLC Patient Advocacy Committee)
Resources:
Slides
Webcast
Lung cancer needs from a psychosocial perspective: An advocate’s point of view
Presenter: Diego Villalon
Session: Living with lung cancer: Meeting unmet needs (LuCE and IASLC Patient Advocacy Committee)
Resources:
Slides
Webcast
In it for the long term: Dealing with treatment effects
Presenter: Merel Hennink
Session: Living with lung cancer: Meeting unmet needs (LuCE and IASLC Patient Advocacy Committee)
Resources:
Slides
Webcast
The impact of lung cancer cachexia
Presenter: Maurizio Muscaritoli
Session: Living with lung cancer: Meeting unmet needs (LuCE and IASLC Patient Advocacy Committee)
Resources:
Slides
Webcast